Category Archives: Compliance

Drug Pricing and Payment Policy: Key 2018 Developments and Potential 2019 Changes and Challenges

Following a number of drug pricing reforms implemented or proposed in 2018, 2019 likely will bring more action from HHS and Congress to reduce drug prices. Key Points: In 2018, the Administration implemented and proposed several policy changes to reduce drug prices or spending, and Congress passed new legislation prohibiting health plans from preventing pharmacies from informing plan… Read More »

Sponsored Post: Reasons to Be Hopeful About the US Health Industry in 2019

* * * * * This post sponsored by PwC. * * * * * The US health industry is showing signs of modernizing along the lines of tech, retail and hospitality, changes that should benefit consumers and the healthcare system overall. Once thought to operate outside the greater US economy, the industry—with its byzantine payment system, complicated… Read More »

Managing Compliance Risks within a Small Organization or with a Smaller Compliance Team

By | December 3, 2018

In the current, ever-changing regulatory environment, smaller compliance teams face unique changes. The OIG’s supplemental Compliance Program Guidance[1] published in 2005 states that ‘there is no single “best” hospital compliance program. Some hospital entities are small and may have limited resources to devote to compliance measures; others are affiliated with well-established, large, multi-facility organizations with a widely dispersed… Read More »

Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads

The Trump Administration is moving full speed ahead with its proposals under the Blueprint to Lower Drug Prices (the “Blueprint”).  Earlier this week, the Centers for Medicare & Medicaid Services (“CMS”) released a proposed rule that would require pharmaceutical manufacturers to disclose the list price of their pharmaceutical products in direct-to-consumer (“DTC”) television ads (the “Proposed Rule”).  This comes only a week… Read More »

New to Healthcare Seminar Registration Open

By | August 8, 2018

The Massachusetts-Rhode Island Chapter will be hosting its annual New to Healthcare Seminar on Friday, September 21, 2018 at Suffolk Law School.  Join us for a great day of healthcare finance basics from leaders in the industry.  The day’s topics include: Fundamentals of Healthcare Finance and Reporting (Erik Lynch, BDO USA LLP) Law, Compliance and Regulations (Timothy Hogan,… Read More »

August 2018: Where Are We Now With 340B?

By | August 1, 2018

It seems like every week, there are multiple new developments in the 340B Drug Discount Program. In just the last few weeks, we have seen a new Senate hearing, a new GAO Report, a new House hearing, and introduction of more than a dozen new bills in Congress that would impact 340B. To understand where things may be… Read More »

Sunshine for Mid-Level Practitioners?

By | June 12, 2018

Late last month, Senators Grassley (R-IA), Brown (D-OH), and Blumenthal (D-CT) introduced the Fighting the Opioid Epidemic with Sunshine Act, a bill that would expand Physician Payment Sunshine Act reporting requirements to cover payments and other transfers of value made to advance practice nurses and physician assistants. As indicated in Senator Grassley’s announcement of the bill, the Senators are tying the expansion… Read More »